TW202126281A - Composition of resident facial mask - Google Patents
Composition of resident facial mask Download PDFInfo
- Publication number
- TW202126281A TW202126281A TW108148699A TW108148699A TW202126281A TW 202126281 A TW202126281 A TW 202126281A TW 108148699 A TW108148699 A TW 108148699A TW 108148699 A TW108148699 A TW 108148699A TW 202126281 A TW202126281 A TW 202126281A
- Authority
- TW
- Taiwan
- Prior art keywords
- composition
- mask
- weight
- skin
- moisturizing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 112
- 230000001815 facial effect Effects 0.000 title claims abstract description 47
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 48
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000006254 rheological additive Substances 0.000 claims abstract description 14
- 239000000080 wetting agent Substances 0.000 claims abstract description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 52
- 235000011187 glycerol Nutrition 0.000 claims description 24
- 239000000654 additive Substances 0.000 claims description 22
- 230000002087 whitening effect Effects 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 230000000996 additive effect Effects 0.000 claims description 14
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 13
- 239000003974 emollient agent Substances 0.000 claims description 12
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 11
- 239000003242 anti bacterial agent Substances 0.000 claims description 9
- 239000013538 functional additive Substances 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 claims description 8
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- 229920005862 polyol Polymers 0.000 claims description 6
- 150000003077 polyols Chemical class 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 4
- 229920000831 ionic polymer Polymers 0.000 claims description 4
- 230000000149 penetrating effect Effects 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 80
- 230000000052 comparative effect Effects 0.000 description 70
- -1 alkyl acrylic acids Chemical class 0.000 description 20
- 229920006037 cross link polymer Polymers 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 210000000434 stratum corneum Anatomy 0.000 description 15
- 229920001451 polypropylene glycol Polymers 0.000 description 14
- 239000000284 extract Substances 0.000 description 13
- 239000006229 carbon black Substances 0.000 description 12
- 239000011858 nanopowder Substances 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 11
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 239000004576 sand Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000003344 environmental pollutant Substances 0.000 description 9
- 231100000719 pollutant Toxicity 0.000 description 9
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- 239000003906 humectant Substances 0.000 description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- GADGVXXJJXQRSA-UHFFFAOYSA-N ethenyl 8-methylnonanoate Chemical compound CC(C)CCCCCCC(=O)OC=C GADGVXXJJXQRSA-UHFFFAOYSA-N 0.000 description 7
- 230000036564 melanin content Effects 0.000 description 7
- 230000035515 penetration Effects 0.000 description 7
- 229920002451 polyvinyl alcohol Polymers 0.000 description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- 244000075850 Avena orientalis Species 0.000 description 5
- 235000007319 Avena orientalis Nutrition 0.000 description 5
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 239000003002 pH adjusting agent Substances 0.000 description 5
- 239000000419 plant extract Substances 0.000 description 5
- 229920001748 polybutylene Polymers 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000020944 retinol Nutrition 0.000 description 5
- 229960003471 retinol Drugs 0.000 description 5
- 239000011607 retinol Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 5
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 4
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 4
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 240000004922 Vigna radiata Species 0.000 description 4
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 4
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 4
- 229940036350 bisabolol Drugs 0.000 description 4
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 4
- 229940120503 dihydroxyacetone Drugs 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 229960000401 tranexamic acid Drugs 0.000 description 4
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940048053 acrylate Drugs 0.000 description 3
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 3
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 239000001054 red pigment Substances 0.000 description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 3
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 2
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000192132 Leuconostoc Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 125000005396 acrylic acid ester group Chemical group 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 2
- 229960003993 chlorphenesin Drugs 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229940038864 hydrogenated olive oil unsaponifiables Drugs 0.000 description 2
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- YSRSBDQINUMTIF-SNVBAGLBSA-N (2r)-decane-1,2-diol Chemical compound CCCCCCCC[C@@H](O)CO YSRSBDQINUMTIF-SNVBAGLBSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- ZTNJGMFHJYGMDR-UHFFFAOYSA-N 1,2-diisocyanatoethane Chemical compound O=C=NCCN=C=O ZTNJGMFHJYGMDR-UHFFFAOYSA-N 0.000 description 1
- 229940058012 1,3-dimethylol-5,5-dimethylhydantoin Drugs 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 1
- KPOYDLLPVNBIGV-UHFFFAOYSA-N 1-phenyl-3-(2,3,4-trichlorophenyl)urea Chemical compound ClC1=C(Cl)C(Cl)=CC=C1NC(=O)NC1=CC=CC=C1 KPOYDLLPVNBIGV-UHFFFAOYSA-N 0.000 description 1
- WAPNOHKVXSQRPX-UHFFFAOYSA-N 1-phenylethanol Chemical compound CC(O)C1=CC=CC=C1 WAPNOHKVXSQRPX-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- UQUKIPYJQWOQCG-UHFFFAOYSA-N C(N)(OCCCC)=O.ICC#CO Chemical compound C(N)(OCCCC)=O.ICC#CO UQUKIPYJQWOQCG-UHFFFAOYSA-N 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 206010050637 Skin tightness Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- KXBFLNPZHXDQLV-UHFFFAOYSA-N [cyclohexyl(diisocyanato)methyl]cyclohexane Chemical compound C1CCCCC1C(N=C=O)(N=C=O)C1CCCCC1 KXBFLNPZHXDQLV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- KQNZLOUWXSAZGD-UHFFFAOYSA-N benzylperoxymethylbenzene Chemical compound C=1C=CC=CC=1COOCC1=CC=CC=C1 KQNZLOUWXSAZGD-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229960005443 chloroxylenol Drugs 0.000 description 1
- 229960003344 climbazole Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 229940097037 decylene glycol Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940107702 grapefruit seed extract Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- JPCBEVHCIJLZFV-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO.CCCCC(O)CO JPCBEVHCIJLZFV-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940067190 mentholatum Drugs 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 108700019599 monomethylolglycine Proteins 0.000 description 1
- BPTXRMBKOXSOGJ-UHFFFAOYSA-N n-chloro-n-phenylhydroxylamine Chemical compound ON(Cl)C1=CC=CC=C1 BPTXRMBKOXSOGJ-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229940060098 populus tremuloides bark extract Drugs 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- YRJKYHIIYRGTCC-UHFFFAOYSA-M potassium;2-hydroxy-4-methoxybenzoate Chemical compound [K+].COC1=CC=C(C([O-])=O)C(O)=C1 YRJKYHIIYRGTCC-UHFFFAOYSA-M 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940101011 sodium hydroxymethylglycinate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045898 sodium stearoyl glutamate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- KDHFCTLPQJQDQI-BDQAORGHSA-M sodium;(4s)-4-amino-5-octadecanoyloxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O KDHFCTLPQJQDQI-BDQAORGHSA-M 0.000 description 1
- CITBNDNUEPMTFC-UHFFFAOYSA-M sodium;2-(hydroxymethylamino)acetate Chemical compound [Na+].OCNCC([O-])=O CITBNDNUEPMTFC-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000001040 synthetic pigment Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Abstract
Description
本發明係有關一種面膜之組成物,特別是有關於一種透明、容易剝除、不緊繃且有效隔離彩妝及抗附著污染物的駐留型面膜之組成物。 The present invention relates to a composition of a facial mask, in particular to a composition of a permanent facial mask that is transparent, easy to peel off, not tight, and effectively isolates makeup and anti-adhesion pollutants.
近來,人們對於臉部的健康及美麗愈趨重視,其中面膜具有保濕、美白、清潔等功效,而成為廣受大眾喜愛及常用的臉部產品。目前,市售面膜包含清洗式面膜、貼片式面膜以及剝除式面膜,其中剝除式面膜的成分一般以聚乙烯醇(polyvinyl alcohol,PVA)/聚乙烯吡咯烷酮(polyvinylpyrrolidone,PVP)為主。 Recently, people pay more and more attention to the health and beauty of the face. Among them, facial masks have moisturizing, whitening, and cleansing effects, and have become popular and commonly used facial products. Currently, commercially available facial masks include cleansing facial masks, patch facial masks, and peel-off facial masks. The peel-off facial masks are generally composed of polyvinyl alcohol (PVA)/polyvinylpyrrolidone (PVP).
雖然前述各種面膜各有許多優點,但是仍有不足之處。舉例而言,清洗式面膜不能在皮膚上形成厚度薄且均勻的富有彈性之薄膜,而無法隔離彩妝及抗附著污染物。再者,貼片式面膜不具透明的外觀,而無法在面膜上彩妝,也無法隔離彩妝及抗附著污染物。此外,PVA/PVP之剝除式面膜雖具有透明的外觀,但是此面膜之透氣性不佳且具緊繃感,而不適於長時間使用,並且在剝除時容易導致角質受 損,以及不能抗附著污染物。 Although the aforementioned various masks have many advantages, they still have shortcomings. For example, a cleansing facial mask cannot form a thin and uniform elastic film on the skin, and cannot isolate makeup and resist adhesion of pollutants. Furthermore, the patch-type mask does not have a transparent appearance, and it cannot apply makeup on the mask, and cannot isolate makeup and resist adhesion of pollutants. In addition, although the peel-off mask of PVA/PVP has a transparent appearance, the mask is not well breathable and has a tight feeling. It is not suitable for long-term use, and it is easy to cause keratinous skin when peeling off. Damage, and cannot resist adhesion of contaminants.
有鑑於此,亟需發展一種駐留型面膜之組成物,以改善習知面膜的上述缺點。 In view of this, there is an urgent need to develop a resident facial mask composition to improve the above-mentioned shortcomings of conventional facial masks.
因此,本發明之一態樣是提供一種駐留型面膜之組成物,藉由控制組成物之成膜劑(A)的使用量以及成膜劑(A)與保濕滲透劑(B)之重量比值,由此形成之面膜提供透明的外觀,經使用一段預設期間後,仍保持良好的舒適感、貼膚度、剝除容易度及保濕效果,又可有效隔離彩妝及抗附著污染物。此外,藉由保濕滲透劑(B)增強活性添加劑(G)的經皮滲透度,以提升活性添加劑(G)的功效。 Therefore, one aspect of the present invention is to provide a composition of a permanent facial mask, by controlling the amount of the film-forming agent (A) used in the composition and the weight ratio of the film-forming agent (A) to the moisturizing penetrant (B) , The resulting mask provides a transparent appearance. After a predetermined period of use, it still maintains a good sense of comfort, adhesion, ease of peeling, and moisturizing effect, and it can effectively isolate makeup and resist adhesion of pollutants. In addition, the moisturizing penetrant (B) enhances the transdermal penetration of the active additive (G) to enhance the efficacy of the active additive (G).
根據本發明之一態樣,提出一種駐留型面膜之組成物。此駐留型面膜之組成物包含成膜劑(A)、保濕滲透劑(B)、流變調節劑(C)、濕潤劑(D)及水(E),其中前述成膜劑(A)包含聚氨酯-35(A-1)。基於前述組成物的總使用量為100重量百分比,前述成膜劑(A)的使用量為大於8重量百分比至小於22重量百分比,且前述成膜劑(A)與前述保濕滲透劑(B)之重量比值為2.4至12。 According to one aspect of the present invention, a composition of a resident facial mask is provided. The composition of the resident facial mask includes a film-forming agent (A), a moisturizing penetrant (B), a rheology modifier (C), a humectant (D) and water (E), wherein the aforementioned film-forming agent (A) includes Polyurethane-35 (A-1). Based on the total usage amount of the aforementioned composition being 100% by weight, the usage amount of the aforementioned film-forming agent (A) is greater than 8% by weight to less than 22% by weight, and the aforementioned film-forming agent (A) and the aforementioned moisturizing penetrant (B) The weight ratio is 2.4 to 12.
依據本發明之一實施例,基於前述組成物的總使用量為100重量百分比,前述成膜劑(A)的使用量為10重量百分比至20重量百分比。 According to an embodiment of the present invention, based on the total usage amount of the aforementioned composition being 100% by weight, the usage amount of the aforementioned film-forming agent (A) is 10% by weight to 20% by weight.
依據本發明之另一實施例,前述保濕滲透劑(B)包含聚氧乙基聚氧丙基聚氧丁基甘油。 According to another embodiment of the present invention, the aforementioned moisturizing penetrant (B) comprises polyoxyethyl polyoxypropyl polyoxybutyl glycerin.
依據本發明之又一實施例,基於前述組成物的總使用量為100重量百分比,前述保濕滲透劑(B)的使用量為0.5重量百分比至5.5重量百分比。 According to another embodiment of the present invention, based on the total usage amount of the aforementioned composition being 100% by weight, the usage amount of the aforementioned moisturizing penetrant (B) is 0.5% to 5.5% by weight.
依據本發明之再一實施例,前述流變調節劑(C)包含丙烯酸及/或其衍生物之聚合物之至少一者。 According to another embodiment of the present invention, the aforementioned rheology modifier (C) includes at least one of acrylic acid and/or its derivative polymer.
依據本發明之另一實施例,基於前述組成物的總使用量為100重量百分比,前述流變調節劑(C)的使用量為0.1重量百分比至2重量百分比。 According to another embodiment of the present invention, based on the total usage amount of the aforementioned composition being 100% by weight, the usage amount of the aforementioned rheology modifier (C) is 0.1% to 2% by weight.
依據本發明之另一實施例,前述濕潤劑(D)係選自於由液狀多元醇、水溶性烷氧基化非離子聚合物及其任意組合所組成之族群。 According to another embodiment of the present invention, the aforementioned wetting agent (D) is selected from the group consisting of liquid polyols, water-soluble alkoxylated non-ionic polymers and any combination thereof.
依據本發明之另一實施例,基於前述組成物的總使用量為100重量百分比,前述濕潤劑(D)的使用量為5重量百分比至8重量百分比。 According to another embodiment of the present invention, based on the total usage amount of the aforementioned composition being 100% by weight, the usage amount of the aforementioned wetting agent (D) is 5 to 8% by weight.
依據本發明之另一實施例,前述駐留型面膜之組成物選擇性包含功能性添加劑(F)及/或活性添加劑(G)。 According to another embodiment of the present invention, the composition of the aforementioned resident mask selectively includes functional additives (F) and/or active additives (G).
依據本發明之另一實施例,前述功能性添加劑(F)係選自於由pH調整劑(F1)、界面活性劑(F2)、潤膚劑(F3)、抗菌劑(F4)及乙醇(F5)所組成之族群之至少一者,活性添加劑(G)係選自於由美白劑(G1)、抗氧化劑(G2)及舒敏劑(G3)所組成之族群之至少一者。 According to another embodiment of the present invention, the aforementioned functional additive (F) is selected from the group consisting of pH adjuster (F1), surfactant (F2), emollient (F3), antibacterial agent (F4) and ethanol ( F5) at least one member of the group consisting of active additives (G) selected from at least one group consisting of whitening agents (G1), antioxidants (G2) and soothing agents (G3).
綜上,應用本發明之駐留型面膜之組成物,塗覆在皮膚上形成駐留型面膜,提供透明的外觀,經使用一段 預設期間後,仍保持良好的舒適感、貼膚度、剝除容易度及保濕效果,又可有效隔離彩妝及抗附著污染物。 In summary, the composition of the resident mask of the present invention is applied to the skin to form a resident mask, which provides a transparent appearance. After the preset period, it still maintains a good sense of comfort, adhesion, ease of peeling, and moisturizing effect, and it can effectively isolate makeup and resist adhesion of pollutants.
為了對本發明之實施例及其優點有更完整之理解,現請參照以下之說明並配合相應之圖式。必須強調的是,各種特徵並非依比例描繪且僅係為了圖解目的。相關圖式內容說明如下: In order to have a more complete understanding of the embodiments of the present invention and its advantages, please refer to the following description and the corresponding drawings. It must be emphasized that the various features are not drawn to scale and are for illustration purposes only. The contents of the relevant diagrams are described as follows:
〔圖1A〕至〔圖1F〕係本發明之一實施例及一些比較例之面膜組成物塗覆於受試者臉部後歷經8小時之照片。 [Fig. 1A] to [Fig. 1F] are photos of an embodiment of the present invention and some comparative examples of the mask composition after being applied to the face of a subject for 8 hours.
〔圖2A〕及〔圖2C〕分別係本發明之一實施例與一比較例之受試者的角質層在塗覆面膜組成物前之照片。 [Fig. 2A] and [Fig. 2C] are photographs of the stratum corneum of a subject of an embodiment of the present invention and a comparative example, respectively, before applying the mask composition.
〔圖2B〕及〔圖2D〕係分別根據圖2A及圖2C之受試者角質層經剝除一實施例與一比較例組成物形成之面膜後之照片。 [Fig. 2B] and [Fig. 2D] are photographs of a mask formed by peeling off the composition of an example and a comparative example according to the stratum corneum of a subject in Figs. 2A and 2C, respectively.
〔圖3A〕係本發明之一實施例與一比較例之透氣膠帶塗佈口紅及粉底之照片。 [Figure 3A] is a photo of a breathable tape coated lipstick and foundation according to an embodiment of the present invention and a comparative example.
〔圖3B〕係緊鄰圖3A的透氣膠帶之紙巾照片。 [Figure 3B] is a photo of the paper towel next to the breathable tape in Figure 3A.
〔圖4A〕係本發明之一實施例與一比較例之豬皮經奈米粉體抗附著性試驗後之照片。 [Figure 4A] is a photograph of pig skins of an example and a comparative example of the present invention after the nano-powder anti-adhesion test.
〔圖4B〕係本發明之一實施例與一比較例之豬皮經碳黑抗附著性試驗後之照片。 [Figure 4B] is a photo of pig skins of an example and a comparative example of the present invention after the carbon black anti-adhesion test.
〔圖4C〕係本發明之一實施例與一比較例之玻片經海砂抗附著性試驗後之照片。 [Figure 4C] is a photograph of a glass slide of an example of the present invention and a comparative example after the sea sand anti-adhesion test.
〔圖5A〕係本發明之一實施例之受試者手臂皮膚經彩妝之照片。 [Figure 5A] is a photo of the subject's arm skin undergoing makeup in an embodiment of the present invention.
〔圖5B〕係根據圖5A之受試者手臂皮膚經移除彩妝處理後的照片。 [Figure 5B] is a photo of the subject's arm skin after makeup removal treatment according to Figure 5A.
〔圖6A〕係本發明之一些實施例與一些比較例之受試者手臂皮膚經過二羥丙酮溶液處理後之照片。 [Fig. 6A] is a photograph of the arm skin of subjects in some examples of the present invention and some comparative examples after being treated with dihydroxyacetone solution.
〔圖6B〕係根據圖6A之受試者手臂皮膚經塗覆或不塗覆本發明之一些實施例與一些比較例之面膜組成物後的照片。 [Figure 6B] is a photo of the subject's arm skin according to Figure 6A after being coated or not coated with the facial mask composition of some embodiments of the present invention and some comparative examples.
以下仔細討論本發明實施例之應用。然而,可以理解的是,實施例提供許多可應用的發明概念,其可實施於各式各樣的特定內容中。所討論之特定實施例僅供說明,並非用以限定本發明之範圍。 The application of the embodiments of the present invention will be discussed in detail below. However, it can be understood that the embodiments provide many applicable inventive concepts, which can be implemented in various specific contents. The specific embodiments discussed are for illustration only, and are not intended to limit the scope of the present invention.
本發明提供一種駐留型面膜之組成物,藉由控制組成物之成膜劑(A)的使用量以及成膜劑(A)與保濕滲透劑(B)之重量比值,由此形成之面膜提供透明的外觀,並經使用一段預設期間後,仍保持良好的舒適感、貼膚度、剝除容易度及保濕效果,又可有效隔離彩妝及抗附著污染物。再者,由於良好的剝除容易度,所以剝除面膜不會導致皮膚角質受損,並且在使用少許的常溫水濕潤面膜後,即可剝除面膜,且同時移除在面膜上的彩妝。此外,藉由保濕滲透劑(B) 增強活性添加劑(G)的經皮滲透度,以提升活性添加劑(G)的功效。 The present invention provides a composition of a resident facial mask, which is provided by controlling the use amount of the film-forming agent (A) of the composition and the weight ratio of the film-forming agent (A) to the moisturizing penetrant (B). Transparent appearance, and after using for a preset period of time, it still maintains a good sense of comfort, skin adhesion, ease of peeling and moisturizing effect, and it can effectively isolate makeup and resist adhesion of pollutants. Furthermore, due to the good peeling ease, peeling off the mask will not cause skin keratinous damage, and after a little room temperature water is used to moisten the mask, the mask can be peeled off and the makeup on the mask can be removed at the same time. In addition, with moisturizing penetrant (B) Enhance the transdermal penetration of the active additive (G) to enhance the efficacy of the active additive (G).
申言之,上述之駐留型面膜之組成物包含成膜劑(A)、保濕滲透劑(B)、流變調節劑(C)、濕潤劑(D)及水(E)。本發明此處所稱的成膜劑(A)係指水性聚合物。在一些實施例中,成膜劑(A)包含但不限於聚氨酯-35(Polyurethane-35)(A-1)。聚氨酯-35(A-1)可為市售商品,例如科思創公司(Covestro)製造之水性聚氨酯,其係由己二酸(adipic acid)、二環己基甲烷二異氰酸酯(dicyclohexylmethane diisocyanate)、乙二胺(ethylenediamine)、己二醇(hexandiol)、新戊二醇(neopentyl glycol)及N-(2-氨基乙基)-3-氨基乙烷磺酸鈉(sodium N-(2-aminoethyl)-3-aminoethanesulfonate)等單體所合成的共聚物。 It is said that the composition of the above-mentioned resident facial mask includes a film-forming agent (A), a moisturizing penetrant (B), a rheology modifier (C), a humectant (D) and water (E). The film-forming agent (A) referred to herein in the present invention refers to an aqueous polymer. In some embodiments, the film former (A) includes but is not limited to Polyurethane-35 (A-1). Polyurethane-35 (A-1) can be commercially available products, such as waterborne polyurethane manufactured by Covestro, which is composed of adipic acid, dicyclohexylmethane diisocyanate, and ethylene diisocyanate. Ethylenediamine, hexandiol, neopentyl glycol and sodium N-(2-aminoethyl)-3 -aminoethanesulfonate) and other monomers synthesized copolymers.
依據本發明之一實施例,基於前述組成物的總使用量為100重量百分比,前述成膜劑(A)的使用量為大於8重量百分比至小於22重量百分比。當成膜劑(A)的使用量等於或小於8重量百分比時,由此形成之面膜的剝除容易度不佳。當成膜劑(A)的使用量等於或大於22重量百分比時,由此形成之面膜會太厚,容易造成皮膚緊繃而舒適感不佳。較佳地,成膜劑(A)的使用量為10重量百分比至20重量百分比。更佳地,成膜劑(A)的使用量為12重量百分比至15重量百分比,由此形成之面膜可提供較佳的舒適感、貼膚度、剝除容易度及保濕效果。 According to an embodiment of the present invention, based on the total usage amount of the aforementioned composition being 100% by weight, the usage amount of the aforementioned film-forming agent (A) is greater than 8% by weight to less than 22% by weight. When the amount of the film-forming agent (A) used is equal to or less than 8% by weight, the mask thus formed is not easily peeled off. When the use amount of the film-forming agent (A) is equal to or greater than 22% by weight, the resulting mask will be too thick, which will easily cause skin tightness and poor comfort. Preferably, the amount of film-forming agent (A) used is 10 to 20 weight percent. More preferably, the amount of the film-forming agent (A) used is 12% to 15% by weight, and the mask formed thereby can provide better comfort, adhesion, ease of peeling, and moisturizing effect.
在本發明之駐留型面膜之組成物中,本發明此處所稱的保濕滲透劑(B)係指藉由提高活性添加劑(G)對於皮膚的溶解度,從而幫助活性添加劑(G)滲透至皮膚內,並增強活性添加劑(G)之功效的保濕劑。在一些實施例中,保濕滲透劑(B)包含但不限於聚氧乙基聚氧丙基聚氧丁基甘油。聚氧乙基聚氧丙基聚氧丁基甘油係將聚氧乙基、聚氧丙基及聚氧丁基加至甘油的三個羥基所得之化合物。在一具體例中,聚氧乙基聚氧丙基聚氧丁基甘油可為PEG/PPG/聚丁基二醇-8/5/3甘油(PEG/PPG/polybutylene glyccl-8/5/3 glycerin)(B)。 In the composition of the resident facial mask of the present invention, the moisturizing penetrant (B) referred to herein in the present invention refers to improving the solubility of the active additive (G) to the skin, thereby helping the active additive (G) to penetrate into the skin It is a humectant that enhances the effect of active additives (G). In some embodiments, the moisturizing penetrant (B) includes, but is not limited to, polyoxyethyl polyoxypropyl polyoxybutyl glycerin. Polyoxyethyl polyoxypropyl polyoxybutyl glycerol is a compound obtained by adding polyoxyethyl, polyoxypropyl and polyoxybutyl to the three hydroxyl groups of glycerin. In a specific example, the polyoxyethyl polyoxypropyl polyoxybutyl glycerin can be PEG/PPG/polybutylene glyccl-8/5/3 glycerin (PEG/PPG/polybutylene glyccl-8/5/3 glycerin) (B).
依據本發明之一實施例,基於前述組成物的總使用量為100重量百分比,前述成膜劑(A)與前述保濕滲透劑(B)之重量比值可為2.4至12。當成膜劑(A)與保濕滲透劑(B)之重量比值小於2.4時,由此形成之面膜無法經水濕潤後整片剝除,或者具有黏膩感。當成膜劑(A)與保濕滲透劑(B)之重量比值大於12時,由此形成之面膜會造成皮膚緊繃而使得使用者感到不適。較佳地,前述成膜劑(A)與前述保濕滲透劑(B)之重量比值為2.4至5。 According to an embodiment of the present invention, based on the total usage of the aforementioned composition being 100% by weight, the weight ratio of the aforementioned film-forming agent (A) to the aforementioned moisturizing penetrant (B) may be 2.4-12. When the weight ratio of the film-forming agent (A) to the moisturizing penetrant (B) is less than 2.4, the resulting mask cannot be peeled off as a whole after being wetted with water, or has a sticky feeling. When the weight ratio of the film-forming agent (A) to the moisturizing penetrant (B) is greater than 12, the resulting mask will cause skin tension and make the user feel uncomfortable. Preferably, the weight ratio of the aforementioned film-forming agent (A) to the aforementioned moisturizing penetrant (B) is 2.4 to 5.
依據本發明之一實施例,基於前述組成物的總使用量為100重量百分比,前述成膜劑(A)的使用量為大於8重量百分比至小於22重量百分比,並且兩者之重量比值為2.4至12時,此組成物可於皮膚上形成外觀透明的面膜,且富有彈性,而能夠提供高貼膚度並且透氣度佳。此外,經使用一段預設期間後,由此形成之面膜仍保持良好的舒適 感、貼膚度、剝除容易度及保濕效果,又可有效隔離彩妝及污染物。 According to an embodiment of the present invention, based on the total usage amount of the aforementioned composition being 100% by weight, the usage amount of the aforementioned film-forming agent (A) is greater than 8% by weight to less than 22% by weight, and the weight ratio between the two is 2.4 At 12 o'clock, the composition can form a transparent facial mask on the skin, and is elastic, and can provide high skin adhesion and good air permeability. In addition, after using for a preset period of time, the resulting mask still maintains good comfort Sensation, adhesion, ease of peeling and moisturizing effect, and can effectively isolate makeup and pollutants.
依據本發明之一實施例,基於上述組成物的總使用量為100重量百分比,前述保濕滲透劑(B)的使用量可為0.5重量百分比至5.5重量百分比。當保濕滲透劑(B)的使用量為0.5重量百分比至5.5重量百分比時,由此形成之面膜具有優越的保濕效果。較佳地,前述保濕滲透劑(B)的使用量為1重量百分比至5重量百分比,且更佳為3重量百分比。 According to an embodiment of the present invention, based on the total usage amount of the aforementioned composition being 100% by weight, the usage amount of the aforementioned moisturizing penetrant (B) may be 0.5% to 5.5% by weight. When the use amount of the moisturizing penetrant (B) is 0.5 wt% to 5.5 wt%, the mask formed thereby has a superior moisturizing effect. Preferably, the use amount of the aforementioned moisturizing penetrant (B) is 1 weight percent to 5 weight percent, and more preferably 3 weight percent.
在駐留型面膜之組成物中,本發明此處所稱的流變調節劑(C)係用以調節組成物的黏稠度,使得組成物能夠均勻塗覆於臉部,而形成厚度薄且均勻的面膜,從而提供使用時透氣的舒適感及良好的貼膚度。在一些實施例中,流變調節劑(C)包含丙烯酸及/或其衍生物之聚合物之至少一者。前述丙烯酸衍生物包含但不限於丙烯酸酯、丙烯酸酯的鹽類、碳數10至30的烷基丙烯酸或丙烯醯胺。在一些實施例中,除了丙烯酸及/或其衍生物之外,前述聚合物亦可包含異癸酸乙烯酯之單體。此外,前述聚合物可為均聚物或共聚物,或者前述聚合物可為交聯聚合物。 In the composition of the resident mask, the rheology modifier (C) of the present invention is used to adjust the viscosity of the composition so that the composition can be evenly coated on the face to form a thin and uniform thickness The mask provides breathable comfort and good skin adhesion during use. In some embodiments, the rheology modifier (C) includes at least one polymer of acrylic acid and/or its derivatives. The aforementioned acrylic acid derivatives include, but are not limited to, acrylic acid esters, salts of acrylic acid esters, alkyl acrylic acids having 10 to 30 carbon atoms, or acrylamides. In some embodiments, in addition to acrylic acid and/or its derivatives, the aforementioned polymer may also include a monomer of vinyl isodecanoate. In addition, the aforementioned polymer may be a homopolymer or a copolymer, or the aforementioned polymer may be a cross-linked polymer.
在一些具體例中,流變調節劑(C)包含但不限於丙烯酸酯共聚物(acrylate copolymer)、聚丙烯酸酯鈉(sodium polyacrylate)、丙烯酸/碳數10至30的烷基丙烯酸交聯聚合物(acrylates/C10-30 alkyl acrylate crosspolymer)、甲基丙烯酸甲酯交聯聚合物(methyl methacrylate crosspolymer)、羥乙基丙烯酸酯/丙烯醯二甲基牛磺酸鈉共聚物(hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer)、丙烯酸酯/異癸酸乙烯酯交聯聚合物(acrylate/vinyl isodecanoate crosspolymer)、丙烯酸/異癸酸乙烯酯交聯聚合物(acrylic acid/vinyl isodecanoate crosspolymer)或丙烯醯二甲基牛磺酸銨/VP共聚物(ammonium acryloyldimethyl taurate/VP copolymer)。在其他具體例中,流變調節劑(C)包含上述之聚合物之至少二者之組合。 In some specific examples, the rheology modifier (C) includes but is not limited to acrylate copolymer, sodium polyacrylate, acrylic acid/C10-30 alkyl acrylic cross-linked polymer (acrylates/C10-30 alkyl acrylate crosspolymer), methyl methacrylate cross-linked polymer (methyl methacrylate crosspolymer), hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, acrylate/vinyl isodecanoate crosspolymer , Acrylic acid/vinyl isodecanoate crosspolymer or ammonium acryloyldimethyl taurate/VP copolymer. In other specific examples, the rheology modifier (C) includes a combination of at least two of the above-mentioned polymers.
依據本發明之一實施例,基於前述組成物的總使用量為100重量百分比,流變調節劑(C)的使用量為0.1重量百分比至2重量百分比。當流變調節劑(C)的使用量為0.1重量百分比至2重量百分比時,由此形成之面膜的厚度薄且均勻,而能提供透氣的舒適感及良好的貼膚度。較佳地,流變調節劑(C)的使用量為0.4重量百分比。 According to an embodiment of the present invention, based on the total usage amount of the aforementioned composition being 100% by weight, the usage amount of the rheology modifier (C) is 0.1% to 2% by weight. When the rheology modifier (C) is used in an amount of 0.1% to 2% by weight, the thickness of the resulting mask is thin and uniform, and can provide breathable comfort and good skin adhesion. Preferably, the usage amount of the rheology modifier (C) is 0.4% by weight.
在駐留型面膜之組成物中,本發明此處所稱的濕潤劑(D)係指在需要剝除面膜時,可幫助水濕潤面膜,而使得面膜能夠容易地整片剝除之親水性化合物。據此,本發明之駐留型面膜之組成物所形成之面膜可輕易剝除而不拉扯皮膚。 In the composition of the resident mask, the humectant (D) referred to herein in the present invention refers to a hydrophilic compound that can help water to moisten the mask when the mask needs to be peeled off, so that the mask can be easily peeled off as a whole. Accordingly, the mask formed by the composition of the resident mask of the present invention can be easily peeled off without pulling the skin.
在一些實施例中,濕潤劑(D)係選自於由液狀多元醇、水溶性烷氧基化非離子聚合物及其任意組合所組成之一族群。液狀多元醇可包含碳數2至8的多元醇。舉例而言,液狀多元醇可為乙二醇、丙二醇、丁二醇、戊二醇 (pentylene glycol)、1,2-己二醇(1,2-hexanediol)、辛乙二醇(caprylyl glycol)、癸二醇(decylene glycol)、甘油、乙基己基甘油(ethylhexyl glycerin)、山梨糖醇、甲基苄醇(methylbenzyl alcohol)及麥芽醇等。水溶性烷氧基化非離子聚合物可包含但不限於聚甘油、二丙二醇(dipropylene glycol)、乙氧基二甘醇(ethoxydiglycol)及乙基己氧基甘油(ethylhexylglycerin)等。在其他實施例中,濕潤劑(D)可選擇性包含但不限於透明質酸、殼聚糖、海藻糖及β-葡聚糖及糖衍生物等。 In some embodiments, the humectant (D) is selected from a group consisting of liquid polyols, water-soluble alkoxylated non-ionic polymers, and any combination thereof. The liquid polyol may include a polyol having 2 to 8 carbon atoms. For example, the liquid polyol can be ethylene glycol, propylene glycol, butylene glycol, pentane glycol (pentylene glycol), 1,2-hexanediol (1,2-hexanediol), caprylyl glycol, decylene glycol, glycerin, ethylhexyl glycerin, sorbose Alcohol, methylbenzyl alcohol and maltol, etc. The water-soluble alkoxylated non-ionic polymer may include, but is not limited to, polyglycerol, dipropylene glycol, ethoxydiglycol, ethylhexylglycerin, and the like. In other embodiments, the humectant (D) may optionally include, but is not limited to, hyaluronic acid, chitosan, trehalose, β-glucan and sugar derivatives, and the like.
依據本發明之一實施例,基於前述組成物的總使用量為100重量百分比,濕潤劑(D)的使用量為5重量百分比至8重量百分比。當濕潤劑(D)的使用量為5重量百分比至8重量百分比時,由其所形成之面膜能夠經水濕潤後整片剝除,以提供使用後剝除的便利性。較佳地,濕潤劑(D)的使用量為5重量百分比。 According to an embodiment of the present invention, based on the total usage amount of the aforementioned composition being 100% by weight, the usage amount of the humectant (D) is 5 to 8% by weight. When the use amount of the humectant (D) is 5 wt% to 8 wt%, the mask formed by it can be peeled off as a whole after being wetted with water to provide the convenience of peeling off after use. Preferably, the amount of wetting agent (D) used is 5 weight percent.
在本發明之駐留型面膜之組成物中,駐留型面膜之組成物可選擇性包含功能性添加劑(F)及/或活性添加劑(G)。本發明此處所稱的功能性添加劑(F)係指能夠提供pH調整、乳化、分散、溶解、潤膚或抗菌等功能之添加劑。在一些實施例中,功能性添加劑(F)係選自於由pH調整劑(F1)、界面活性劑(F2)、潤膚劑(F3)、抗菌劑(F4)及乙醇(F5)所組成之族群之至少一者。活性添加劑(G)係指能夠提供美白、抗氧化或舒敏等功能之添加劑。在一些實施例中, 活性添加劑(G)係選自於由美白劑(G1)、抗氧化劑(G2)及舒敏劑(G3)所組成之族群之至少一者。 In the composition of the resident mask of the present invention, the composition of the resident mask may optionally include functional additives (F) and/or active additives (G). The functional additive (F) referred to herein in the present invention refers to an additive capable of providing functions such as pH adjustment, emulsification, dispersion, dissolution, emollient, or antibacterial. In some embodiments, the functional additive (F) is selected from the group consisting of pH adjuster (F1), surfactant (F2), emollient (F3), antibacterial agent (F4) and ethanol (F5) At least one of the ethnic groups. Active additives (G) refer to additives that can provide whitening, anti-oxidation or soothing functions. In some embodiments, The active additive (G) is selected from at least one of the group consisting of whitening agent (G1), antioxidant (G2) and soothing agent (G3).
在此說明的是,本發明的駐留型面膜之組成物藉由保濕滲透劑(B)可增強活性添加劑(G)的經皮滲透度,以提升活性添加劑(G)的功效。 It is explained here that the composition of the resident facial mask of the present invention can enhance the transdermal penetration of the active additive (G) through the moisturizing penetrant (B), so as to enhance the effect of the active additive (G).
駐留型面膜之組成物係直接塗覆於臉部皮膚,可利用pH調整劑(F1)調整前述組成物的pH值,使其與皮膚的pH值接近,進而避免刺激皮膚,其中組成物的pH值可為5至8,較佳為6至7。pH調整劑(F1)包含但不限於小分子的有機胺類、有機弱酸或無機鹼鹽。有機胺類包含但不限於鹼性胺基酸或低級碳的胺醇類。舉例而言,pH調整劑(F1)可為精胺酸(arginine)、2-胺基-2-甲基-1-丙醇、2-胺基-2-甲基-1,3-丙二醇、三乙醇胺(triethanolamine)或檸檬酸等。無機鹼鹽包含但不限於鹼金屬鹽。舉例而言,鹼金屬鹽包含但不限於氫氧化鈉或氫氧化鉀等。 The composition of the permanent mask is directly applied to the facial skin. The pH value of the aforementioned composition can be adjusted by the pH adjuster (F1) to make it close to the pH value of the skin, thereby avoiding skin irritation. The pH of the composition The value can be from 5 to 8, preferably from 6 to 7. The pH adjuster (F1) includes, but is not limited to, small molecules of organic amines, organic weak acids or inorganic base salts. Organic amines include but are not limited to basic amino acids or lower carbon amino alcohols. For example, the pH adjusting agent (F1) can be arginine, 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1,3-propanediol, Triethanolamine or citric acid, etc. Inorganic base salts include, but are not limited to, alkali metal salts. For example, the alkali metal salt includes but is not limited to sodium hydroxide or potassium hydroxide and the like.
在本發明之駐留型面膜之組成物中,界面活性劑(F2)可作為乳化劑、助溶劑及安定劑等。在一些實施例中,界面活性劑(F2)包含陰離子界面活性劑及非離子界面活性劑。 In the composition of the resident facial mask of the present invention, the surfactant (F2) can be used as an emulsifier, a cosolvent, a stabilizer, etc. In some embodiments, the surfactant (F2) includes an anionic surfactant and a nonionic surfactant.
在本發明中,對於界面活性劑(F2)沒有特別的限制,如一般習知可以添加於面膜的組成物之界面活性劑均可以使用。舉例而言,陰離子界面活性劑包含但不限於硬脂醯谷氨酸鈉(sodium stearoyl glutamate)、鯨蠟醇磷酸酯鉀(potassium cetyl phosphate)及磷酸酯鹽等。磷酸酯鹽 的具體例可為卵磷脂(lecithin)、羥基化卵磷脂(hydroxylated lecithin)及氫化卵磷脂(hydrogenated lecithin)等,其中氫化卵磷脂為經過氫化的卵磷脂,且具有適度的皮膚黏著力及對水的分散性,因此氫化卵磷脂可增加組成物形成之面膜用手剝除的容易度。 In the present invention, there is no particular limitation on the surfactant (F2). As generally known, surfactants that can be added to the composition of the mask can be used. For example, anionic surfactants include, but are not limited to, sodium stearoyl glutamate, potassium cetyl phosphate, and phosphate salts. Phosphate Salt Specific examples of lecithin (lecithin), hydroxylated lecithin (hydroxylated lecithin), hydrogenated lecithin (hydrogenated lecithin), etc., wherein hydrogenated lecithin is hydrogenated lecithin, and has moderate skin adhesion and water resistance. Therefore, hydrogenated lecithin can increase the ease of peeling off the mask formed by the composition by hand.
舉例而言,非離子界面活性劑包含但不限於山梨糖醇酐脂肪酸酯、山梨糖醇脂肪酸酯、脂肪酸酯及烷基醚等。脂肪酸酯的具體例可為氫化橄欖油酸乙基己酯(hydrogenated ethylhexyl olivate)及氫化橄欖油不皂化物(hydrogenated olive oil unsaponifiables)等。氫化橄欖油酸乙基己酯及氫化橄欖油不皂化物可當作乳化劑使用,以幫助添加於組成物中的油性分子乳化。 For example, nonionic surfactants include, but are not limited to, sorbitan fatty acid esters, sorbitol fatty acid esters, fatty acid esters, and alkyl ethers. Specific examples of fatty acid esters may be hydrogenated ethylhexyl olivate, hydrogenated olive oil unsaponifiables, and the like. Ethylhexyl hydrogenated olive oil and unsaponifiables of hydrogenated olive oil can be used as emulsifiers to help emulsify the oily molecules added to the composition.
在功能性添加劑(F)中,潤膚劑(F3)能夠滋潤皮膚,而使得皮膚柔嫩。有一些潤膚劑(F3)可以當作水分的封閉劑。當潤膚劑(F3)在皮膚的角質層外形成保護膜時,此保護膜可防止水分流失,從而使肌膚水嫩透亮。 Among the functional additives (F), emollients (F3) can moisturize the skin and make the skin soft. Some emollients (F3) can be used as moisture sealants. When the emollient (F3) forms a protective film outside the stratum corneum of the skin, this protective film can prevent the loss of moisture, thereby making the skin supple and translucent.
在本發明中,對於潤膚劑(F3)沒有特別的限制,如一般習知可以添加於面膜的組成物之潤膚劑均可以使用。在一些實施例中,潤膚劑(F3)包含但不限於脂肪酸及其酯、膽固醇(cholesterol)及其酯或胺基酸衍生物、玻尿酸及其鹽等化合物。在一些實施例中,潤膚劑(F3)包含但不限於動物及/或植物之天然萃取物。舉例而言,潤膚劑(F3)可為辛酸/癸酸甘油三酯(caprylic/capric triglyceride)、荷荷巴油、蘆薈萃取物、玻尿酸鈉及膠原蛋白等。 In the present invention, there is no particular limitation on the emollient (F3), and any emollient that can be added to the composition of the facial mask can be used. In some embodiments, the emollient (F3) includes but is not limited to fatty acid and its ester, cholesterol (cholesterol) and its ester or amino acid derivative, hyaluronic acid and its salt and other compounds. In some embodiments, the emollient (F3) includes, but is not limited to, natural extracts of animals and/or plants. For example, the emollient (F3) can be caprylic/capric triglyceride, jojoba oil, aloe extract, sodium hyaluronate, collagen, etc.
在功能性添加劑(F)中,抗菌劑(F4)藉由殺死導致皮膚長面皰及/或發炎的細菌或者抑制前述細菌的生長及/或菌數增加等方式來阻止或降低皮膚長面皰、發炎或紅腫等狀況。 Among the functional additives (F), the antibacterial agent (F4) prevents or reduces skin pimples by killing the bacteria that cause skin pimples and/or inflammation or inhibiting the growth of the aforementioned bacteria and/or the increase in bacterial count. Conditions such as inflammation or redness.
在本發明中,對於抗菌劑(F4)沒有特別的限制,如一般習知可以添加於面膜的組成物之抗菌劑均可以使用。在一些實施例中,抗菌劑(F4)包含但不限於人工合成的化合物及/或天然植物萃取物。 In the present invention, there is no particular limitation on the antibacterial agent (F4), and any antibacterial agent that can be added to the composition of the facial mask can be used. In some embodiments, the antibacterial agent (F4) includes, but is not limited to, synthetic compounds and/or natural plant extracts.
舉例而言,前述人工合成的化合物可為氯化苄烷銨、三氯對稱二苯脲、三氯沙(triclosan)、異丙基甲基酚(isopropyl methylphenol)、過氧化苯甲醯、水楊酸(salicylic acid)、2-溴-2硝基丙烷-1,3二醇、碘丙炔醇丁基氨甲酸酯、羥甲基甘氨酸鈉、雙咪唑烷基脲、三氯卡班(triclocarban)、對氯間二甲苯酚(chloroxylenol)、氯咪巴唑(climbazole)、吡羅克酮乙醇胺鹽(piroctone olamine)、吡硫翁鋅(zinc pyrithione)及硫磺(sulfur)等。舉例而言,前述天然植物萃取物可為茶樹精油、尤加利精油、薄荷萃取物、白楊樹皮萃取物(populus tremuloides bark extract)、金合歡醇(farnesol)及西洋蓍草萃取物等。 For example, the aforementioned artificially synthesized compound can be benzalkonium chloride, trichlorodiphenylurea, triclosan, isopropyl methylphenol, benzyl peroxide, salicin. Salicylic acid, 2-bromo-2-nitropropane-1,3 diol, iodopropynol butyl carbamate, sodium hydroxymethyl glycinate, bisimidazolidinyl urea, triclocarban ), chloroxylenol, climbazole, piroctone olamine, zinc pyrithione, sulfur, etc. For example, the aforementioned natural plant extracts may be tea tree essential oil, eucalyptus essential oil, peppermint extract, populus tremuloides bark extract, farnesol, yarrow extract, and the like.
在一些實施例中,抗菌劑(F4)包含但不限於蜂膠或明串球菌/蘿蔔根發酵濾液(leuconostoc/radish root ferment filtrate)等。在其他實施例中,上述之抗菌劑(F4)的複數個具體例亦可混合使用。 In some embodiments, the antibacterial agent (F4) includes, but is not limited to, propolis or Leuconostoc/radish root ferment filtrate (leuconostoc/radish root ferment filtrate) and the like. In other embodiments, multiple specific examples of the aforementioned antibacterial agent (F4) can also be used in combination.
在活性添加劑(G)中,美白劑(G1)係用於預防、抑制及/或減少皮膚黑色素的生成及/或沉澱等,並藉此達成美白效果。本發明此處所稱的美白效果係指皮膚經過30%二羥丙酮(dihydroxyacetone)溶液處理40分鐘後,等待角質充分褐化後,塗覆駐留式面膜之組成物,經8小時後剝除,以每日一次的頻率連續進行5日,再使用皮膚黑/紅色素探棒及皮膚色澤度探棒測定皮膚之表皮黑色素含量及L值,以獲得個體類型角(individual typological angle,ITA),並計算黑色素含量、L值及ITA之變化率,所進行之評估的美白效果。 Among the active additives (G), the whitening agent (G1) is used to prevent, inhibit and/or reduce the production and/or precipitation of melanin in the skin, thereby achieving a whitening effect. The whitening effect referred to here in the present invention means that the skin is treated with a 30% dihydroxyacetone solution for 40 minutes, and after the keratin is fully browned, the composition of the resident mask is applied, and the skin is peeled off after 8 hours. Once a day for 5 consecutive days, use the skin black/red pigment probe and the skin tone probe to measure the epidermal melanin content and L value of the skin to obtain the individual typological angle (ITA), and calculate The change rate of melanin content, L value and ITA, the whitening effect evaluated.
在本發明中,對於美白劑(G1)沒有特別的限制,如一般習知可以添加於面膜的組成物之美白劑均可以使用。在一些實施例中,美白劑(G1)包含但不限於人工合成的化合物及/或天然植物萃取物。舉例而言,美白劑(G1)可為菸鹼醯胺(nicotinamide)、傳明酸(tranexamic acid)及4-甲氧基水楊酸鉀(potassium 4-methoxysalicylate)等。 In the present invention, there is no particular restriction on the whitening agent (G1), and any whitening agent that can be added to the composition of the facial mask can be used. In some embodiments, the whitening agent (G1) includes, but is not limited to, synthetic compounds and/or natural plant extracts. For example, the whitening agent (G1) can be nicotinamide, tranexamic acid, potassium 4-methoxysalicylate, and the like.
在活性添加劑(G)中,抗氧化劑(G2)可減少自由基,從而阻止皮膚受到自由基的傷害,以藉此產生抗老化的效果且使得肌膚保持年輕。 Among the active additives (G), antioxidants (G2) can reduce free radicals, thereby preventing the skin from being damaged by free radicals, thereby producing anti-aging effects and keeping the skin youthful.
在本發明中,對於抗氧化劑(G2)沒有特別的限制,如一般習知可以添加於面膜的組成物之抗氧化劑均可以使用。在一些實施例中,抗氧化劑(G2)包含但不限於人工合成的化合物及/或天然植物萃取物。 In the present invention, there is no particular restriction on the antioxidant (G2), and any antioxidant that can be added to the composition of the mask can be used as it is generally known. In some embodiments, antioxidants (G2) include, but are not limited to, synthetic compounds and/or natural plant extracts.
舉例而言,前述人工合成的化合物可為視黃醇(retinol)、丁羥甲苯(dibutyl hydroxy toluene,BHT)、丁羥茴醚(butylated hydroxy anisole,BHA)、生育酚乙酸酯(tocopheryl acetate)、棓酸丙酯、生育酚、t-丁基氫醌、抗壞血酸(維生素C)及二月桂醇硫代二丙酸酯等。前述天然植物萃取物可為薏仁萃取物、櫻桃萃取物及葡萄籽萃取物(grapefruit seed extract)等。 For example, the aforementioned synthetic compound may be retinol, dibutyl hydroxy toluene (BHT), butylated hydroxy anisole (BHA), and tocopheryl acetate (tocopheryl acetate). , Propyl gallate, tocopherol, t-butyl hydroquinone, ascorbic acid (vitamin C) and dilauryl thiodipropionate, etc. The aforementioned natural plant extracts may be coix seed extract, cherry extract, grapefruit seed extract, and the like.
本發明的舒敏劑(G3)用於舒緩皮膚遭遇到刺激所引發之紅腫或刺痛等過敏反應。在一些實施例中,舒敏劑(G3)包含但不限於沒藥醇及薑根萃取物、燕麥粗粉萃取物(avena sativa(oat)meal extract)及綠豆籽萃取物(phaseolus radiatus seed extract)等。 The soothing agent (G3) of the present invention is used to relieve allergic reactions such as redness, swelling or tingling caused by skin irritation. In some embodiments, the soothing agent (G3) includes but is not limited to bisabolol and ginger root extract, avena sativa (oat) meal extract and mung bean seed extract (phaseolus radiatus seed extract) Wait.
除了上述之組成份之外,在一些實施例中,本發明之駐留型面膜之組成物可選擇性包含但不限於防腐劑、金屬螯合劑、色素或香料等。 In addition to the above-mentioned components, in some embodiments, the composition of the resident facial mask of the present invention may optionally include, but is not limited to, preservatives, metal chelating agents, pigments or fragrances.
舉例而言,但不為限制本發明之範圍,防腐劑可為對羥基苯甲酸酯(paraben)、羥基氯苯胺、苯氧乙醇(phenoxyethanol)、苯甲醇(benzyl alcohol)、苯甲酸(benzoic acid)、苯甲酸鈉(sodium benzoate)、咪唑烷基脲(imidazolidiny urea)、1,3-二羥甲基-5,5-二甲基乙內醯脲(1,3-dimethylol-5,5-dimethylhydantoin,DMDM hydantoin)、甲醛(formaldehyde)、山梨酸、氯苯甘醚(chlorphenesin)、甲基氯異塞唑晽酮(methylchloroisothiazolinone)、2-溴-2-硝基-1,3-丙二 醇(2-bromo-2-nitropropane-1,3-diol)、己二烯酸鉀(potassium sorbate)、己二烯酸(sorbic acid)、碘丙炔正丁胺甲酸酯(iodopropynyl butylcarbamate)等。金屬螯合劑可為乙二胺四乙酸(EDTA)等。色素可為人工合成的色素及/或天然的色素,並且舉凡所有的法定化妝品色素皆可用於本發明。香料可為人工合成的香料及/或天然的香料。香料的具體例可為玫瑰香精、薰衣草香精或百合花香精等。 For example, but not to limit the scope of the present invention, the preservative may be paraben, hydroxychloroaniline, phenoxyethanol, benzyl alcohol, benzoic acid ), sodium benzoate, imidazolidiny urea, 1,3-dimethylol-5,5-dimethylhydantoin , DMDM hydantoin), formaldehyde (formaldehyde), sorbic acid, chlorphenesin (chlorphenesin), methylchloroisothiazolinone (methylchloroisothiazolinone), 2-bromo-2-nitro-1,3-propane Alcohol (2-bromo-2-nitropropane-1,3-diol), potassium sorbate, sorbic acid, iodopropynyl butylcarbamate, etc. The metal chelating agent may be ethylenediaminetetraacetic acid (EDTA) and the like. The pigments can be synthetic pigments and/or natural pigments, and all legal cosmetic pigments can be used in the present invention. The fragrance can be a synthetic fragrance and/or a natural fragrance. Specific examples of flavors can be rose flavor, lavender flavor, lily flavor, and the like.
藉由控制組成物之成膜劑(A)的使用量在大於8重量百分比至小於22重量百分比之範圍以及成膜劑(A)與保濕滲透劑(B)之重量比值在2.4至12之範圍,由此形成之面膜具有透明外觀,經使用一段預設期間後,經評價後,確實能提供良好的舒適感、貼膚度、剝除容易度及保濕效果,又可有效隔離彩妝及抗附著污染物。 By controlling the use amount of the film-forming agent (A) of the composition in the range of greater than 8 weight percent to less than 22 weight percent, and the weight ratio of the film-forming agent (A) to the moisturizing penetrant (B) in the range of 2.4 to 12 , The resulting mask has a transparent appearance. After being used for a preset period of time, after evaluation, it can indeed provide good comfort, adhesion, ease of peeling and moisturizing effect, and it can effectively isolate makeup and resist adhesion Pollutants.
本發明前述所稱的預設期間係指在駐留型面膜之組成物塗覆於臉部後經過的一段預設期間。在一些實施例中,預設期間可為6小時至12小時。較佳地,預設期間可為8小時。 The aforementioned predetermined period of the present invention refers to a predetermined period of time after the composition of the resident mask is applied to the face. In some embodiments, the preset period may be 6 hours to 12 hours. Preferably, the preset period may be 8 hours.
以下利用實施例以說明本發明之應用,然其並非用以限定本發明,任何熟習此技術者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾。 The following examples are used to illustrate the application of the present invention, but they are not intended to limit the present invention. Anyone familiar with the technology can make various changes and modifications without departing from the spirit and scope of the present invention.
在實施例1中,將0.3重量百分比的丙烯酸(酯)/異癸酸乙烯酯交聯聚合物(C-1)、0.1重量百分比的丙烯酸/碳數10至30的烷基丙烯酸交聯聚合物(C-2)、5重量 百分比的二丙二醇(D-1)、0.02重量百分比的檸檬酸(F1-2)及70.3重量百分比的水(E)混合後,攪拌以形成均勻分散的水相溶液,再將3重量百分比的PEG/PPG/聚丁基二醇-8/5/3甘油(B)(商品名:S-753,日油株式會社(WILBRIDE)製造)、2重量百分比的菸鹼醯胺(G1-1)、2重量百分比的傳明酸(G1-2)、1重量百分比的沒藥醇及薑根萃取物(G3-1及G3-2)、0.18重量百分比的精胺酸(F1-1)與1重量百分比的氫化橄欖油酸乙基己酯/氫化橄欖油不皂化物(F2-1)加入至攪拌中的前述水相溶液均勻混合。另一方面,將5重量百分比的乙醇(F5)及0.1重量百分比的異丙基甲基酚(F4)混合攪拌後以形成透明抗菌溶液,然後,緩慢加入至攪拌中的前述水相溶液。在均勻混合後再加入10重量百分比的聚氨酯-35(A-1)(商品名:C1004,科思創公司製造),持續攪拌至均相,以獲得實施例1的面膜組成物。 In Example 1, 0.3% by weight of acrylic acid (ester)/vinyl isodecanoate crosslinked polymer (C-1), 0.1% by weight of acrylic acid/C10-30 alkyl acrylic acid crosslinked polymer (C-2), 5 weight Percent of dipropylene glycol (D-1), 0.02% by weight of citric acid (F1-2) and 70.3% by weight of water (E) are mixed, stirred to form a uniformly dispersed aqueous solution, and then 3% by weight of PEG /PPG/polybutyl glycol-8/5/3 glycerin (B) (trade name: S-753, manufactured by NOF Corporation (WILBRIDE)), 2 weight percent nicotine amide (G1-1), 2 weight percent of tranexamic acid (G1-2), 1 weight percent of bisabolol and ginger root extract (G3-1 and G3-2), 0.18 weight percent of arginine (F1-1) and 1 weight percent The percentage of hydrogenated ethylhexyl olive oil/hydrogenated olive oil unsaponifiable (F2-1) is added to the aforementioned aqueous solution during stirring and mixed uniformly. On the other hand, 5 weight percent of ethanol (F5) and 0.1 weight percent of isopropyl methylphenol (F4) are mixed and stirred to form a transparent antibacterial solution, and then slowly added to the agitated aqueous phase solution. After uniformly mixing, 10 weight percent of polyurethane-35 (A-1) (trade name: C1004, manufactured by Covestro) is added, and stirring is continued to a homogeneous phase to obtain the facial mask composition of Example 1.
實施例2至實施例7及比較例1至比較例5皆以與實施例1相同的方法進行配製。不同的是,實施例2至實施例4及比較例1至比較例2的聚氨酯-35(A-1)之使用量與實施例1不同。實施例5至實施例6及比較例4的聚氨酯-35(A-1)之使用量及PEG/PPG/聚丁基二醇-8/5/3甘油(B)之使用量與實施例1不同。實施例7的聚氨酯-35(A-1)之使用量與實施例1不同,並且以羥乙基丙烯酸酯/丙烯醯二甲基牛磺酸鈉共聚合物(C-4)取代丙烯酸(酯)/異癸酸乙烯酯交聯聚合物(C-1)及丙烯酸/碳數10至30的 烷基丙烯酸交聯聚合物(C-2)。比較例3的聚氨酯-35(A-1)之使用量、PEG/PPG/聚丁基二醇-8/5/3甘油(B)之使用量及二丙二醇(D-1)之使用量與實施例1不同。比較例5使用聚乙烯醇(A-2)及聚乙烯吡咯烷酮(A-3)取代聚氨酯-35(A-1)。關於實施例2至實施例7及比較例1至比較例5的具體條件如表1所示。 Example 2 to Example 7 and Comparative Example 1 to Comparative Example 5 were all prepared in the same way as Example 1. The difference is that the usage amount of polyurethane-35 (A-1) of Example 2 to Example 4 and Comparative Example 1 to Comparative Example 2 is different from that of Example 1. The usage amount of polyurethane-35 (A-1) and the usage amount of PEG/PPG/polybutyl glycol-8/5/3 glycerin (B) of Example 5 to Example 6 and Comparative Example 4 are the same as that of Example 1. different. The usage amount of polyurethane-35 (A-1) of Example 7 is different from that of Example 1, and the hydroxyethyl acrylate/sodium acrylate dimethyl taurate copolymer (C-4) is substituted for the acrylic acid (ester). )/Vinyl isodecanoate cross-linked polymer (C-1) and acrylic acid/C10-30 Alkyl acrylic acid cross-linked polymer (C-2). The usage amount of polyurethane-35 (A-1), the usage amount of PEG/PPG/polybutyl glycol-8/5/3 glycerin (B) and the usage amount of dipropylene glycol (D-1) of Comparative Example 3 Example 1 is different. In Comparative Example 5, polyvinyl alcohol (A-2) and polyvinylpyrrolidone (A-3) were used instead of polyurethane-35 (A-1). The specific conditions of Example 2 to Example 7 and Comparative Example 1 to Comparative Example 5 are shown in Table 1.
實施例8以與實施例1相同的方法進行配製。不同的是,實施例8的聚氨酯-35(A-1)之使用量與實施例1不同,並且添加甘油(D-2)、辛酸/癸酸甘油三酯(F3-1)、甲基丙烯酸甲酯交聯聚合物(C-3)、視黃醇(G2-1)、氫化卵磷脂(F2-2)、膽固醇(F3-2)、丁羥甲苯(G2-2)、生育酚乙酸酯(G2-4)、綠豆籽萃取物(G3-3)、丁羥茴醚(G2-3)及燕麥粗粉萃取物(G3-4)。關於實施例8的具體條件如表1所示。 Example 8 was prepared in the same way as Example 1. The difference is that the amount of polyurethane-35 (A-1) used in Example 8 is different from that in Example 1, and glycerin (D-2), caprylic/capric triglyceride (F3-1), and methacrylic acid are added. Methyl ester cross-linked polymer (C-3), retinol (G2-1), hydrogenated lecithin (F2-2), cholesterol (F3-2), butylated hydroxytoluene (G2-2), tocopherol acetic acid Ester (G2-4), mung bean seed extract (G3-3), butylated hydroxyanisole (G2-3) and oat meal extract (G3-4). The specific conditions of Example 8 are shown in Table 1.
實施例9至實施例10及比較例6至比較例7以與實施例8相同的方法進行配製。不同的是,實施例9至實施例10及比較例6的PEG/PPG/聚丁基二醇-8/5/3甘油(B)之使用量與實施例8不同。比較例7的PEG/PPG/聚丁基二醇-8/5/3甘油(B)之使用量及二丙二醇(D-1)之使用量與實施例8不同。關於實施例9至實施例10及比較例6至比較例7的具體條件如表1所示。 Example 9 to Example 10 and Comparative Example 6 to Comparative Example 7 were prepared in the same manner as Example 8. The difference is that the usage amount of PEG/PPG/polybutyl glycol-8/5/3 glycerol (B) in Examples 9 to 10 and Comparative Example 6 is different from that in Example 8. The usage amount of PEG/PPG/polybutyl glycol-8/5/3 glycerin (B) and the usage amount of dipropylene glycol (D-1) in Comparative Example 7 are different from those in Example 8. The specific conditions of Example 9 to Example 10 and Comparative Example 6 to Comparative Example 7 are shown in Table 1.
比較例8係使用由曼秀雷敦公司製造,產品名為肌研PHOTO極潤完美高保濕多效面膜(或稱為Hadalab保濕凝膠面膜,https://jp.rohto.com/hadalabo/rich-gokujun-perfect-mask/),且其為一種貼片式面膜。 Comparative Example 8 uses the product made by Mentholatum, and the product name is Hada Labo Photo Extremely Moisturizing Multi-Effect Mask (or Hadalab Moisturizing Gel Mask, https://jp.rohto.com/hadalabo/rich-gokujun-perfect -mask/), and it is a patch type mask.
表1
註:在單一實施例中所有的星號(*)標記之使用量的總和為5重量百分比。在單一實施例中所有的井字號(#)標記之使用量的總和為1重量百分比。 Note: In a single example, the total amount of all asterisks (*) marked with the amount used is 5 weight percent. In a single embodiment, the sum of the usage amount of all the hash marks (#) is 1 weight percent.
A-1 聚氨酯-35(polyurethane-35) A-1 Polyurethane-35 (polyurethane-35)
A-2 聚乙烯醇(polyvinyl alcohol,PVA) A-2 Polyvinyl alcohol (PVA)
A-3 聚乙烯吡咯烷酮(polyvinylpyrrolidone,PVP) A-3 Polyvinylpyrrolidone (PVP)
B PEG/PPG/聚丁基二醇-8/5/3甘油(PEG/PPG/polybutylene glycol-8/5/3 glycerin) B PEG/PPG/polybutylene glycol-8/5/3 glycerin (PEG/PPG/polybutylene glycol-8/5/3 glycerin)
C-1 丙烯酸(酯)類/異癸酸乙烯酯交聯聚合物(acrylates/vinyl isodecanoate crosspolymer) C-1 Acrylics/vinyl isodecanoate crosspolymer (acrylates/vinyl isodecanoate crosspolymer)
C-2 丙烯酸/碳數10至30的烷基丙烯酸交聯聚合物(acrylate/C10-30 alkyl acrylate crosspolymer) C-2 Acrylic acid/C10-30 alkyl acrylate crosspolymer (acrylate/C10-30 alkyl acrylate crosspolymer)
C-3 甲基丙烯酸甲酯交聯聚合物(methyl methacrylate crosspolymer) C-3 methyl methacrylate crosspolymer
C-4 羥乙基丙烯酸酯/丙烯醯基二甲基牛磺酸鈉共聚合物(hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer) C-4 hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer
D-1 二丙二醇(dipropylene glycol) D-1 dipropylene glycol
D-2 甘油(glycerin) D-2 Glycerin (glycerin)
E 水 E water
F1-1 精胺酸(arginine) F1-1 arginine
F1-2 檸檬酸(citric acid) F1-2 Citric acid
F2-1 氫化橄欖油酸乙基己酯/氫化橄欖油不皂化物(hydrogenated ethylhexyl olivate/hydrogenated olive oil unsaponifiables) F2-1 Hydrogenated ethylhexyl olivate/hydrogenated olive oil unsaponifiables
F2-2 氫化卵磷脂(hydrogenated lecithin) F2-2 hydrogenated lecithin (hydrogenated lecithin)
F3-1 辛酸/癸酸甘油三酯(caprylic/capric triglyceride) F3-1 Caprylic/capric triglyceride
F3-2 膽固醇(cholesterol) F3-2 cholesterol (cholesterol)
F4 異丙基甲基酚(isopropyl methylphenol) F4 isopropyl methylphenol
F5 乙醇(ethanol) F5 ethanol
G1-1 菸鹼醯胺(niacinamide) G1-1 Nicotinamide (niacinamide)
G1-2 傳明酸(tranexamic acid) G1-2 tranexamic acid
G2-1 視黃醇(retinol) G2-1 Retinol (retinol)
G2-2 丁羥甲苯(dibutyl hydroxy toluene,BHT) G2-2 Dibutyl hydroxy toluene (BHT)
G2-3 丁羥茴醚(butylated hydroxyanisole,BHA) G2-3 butylated hydroxyanisole (BHA)
G2-4 生育酚乙酸酯(tocopheryl acetate) G2-4 tocopheryl acetate
G3-1 沒藥醇(bisabolol) G3-1 Bisabolol (bisabolol)
G3-2 薑根萃取物(zingiber officinale(ginger)root extract) G3-2 Ginger root extract (zingiber officinale(ginger) root extract)
G3-3 綠豆籽萃取物(phaseolus radiatus seed extract) G3-3 Phaseolus radiatus seed extract
G3-4 燕麥粗粉萃取物(avena sativa(oat)meal extract) G3-4 Oatmeal extract (avena sativa(oat)meal extract)
1.舒適感1. Comfort
本發明所稱之舒適感係將實施例1至實施例7及比較例1至比較例5的面膜組成物塗覆於受試者之臉部,其中實施例及比較例各有50位受試者進行舒適感試驗。在歷經八小時後,根據上述受試者之臉部皮膚的主觀感覺進行評價,且具體評價標準如下,其結果如表2所示。 The comfort in the present invention refers to applying the mask composition of Examples 1 to 7 and Comparative Examples 1 to 5 to the faces of subjects, in which there are 50 subjects in each of the Examples and Comparative Examples The person conducts a comfort test. After eight hours, the evaluation was conducted based on the subjective sensation of the facial skin of the above subjects, and the specific evaluation criteria are as follows, and the results are shown in Table 2.
5點:舒適感非常高 5 points: comfort is very high
4點:舒適感高 4 points: high comfort
3點:普通 3 points: normal
2點:舒適感低 2 points: low comfort
1點:舒適感非常低 1: The comfort is very low
2.貼膚度2. Skin fit
本發明所稱之貼膚度係將實施例1至實施例7及比較例1至比較例5的面膜組成物塗覆於受試者之臉部,其中實施例及比較例各有50位受試者進行貼膚度試驗。在歷經八小時後,觀察面膜貼附於皮膚的附著度進行評價,且其具體評價標準如下,其結果如表2及圖1A至圖1F所示。 The degree of skin adhesion referred to in the present invention refers to applying the mask composition of Examples 1 to 7 and Comparative Examples 1 to 5 to the face of the test subject, wherein each of the Examples and Comparative Examples has 50 recipients. Participants conduct a skin adhesion test. After eight hours, the degree of adhesion of the mask to the skin was observed for evaluation, and the specific evaluation criteria were as follows. The results are shown in Table 2 and Figures 1A to 1F.
5點:附著度非常高,面膜邊緣無任何翻翹 5 points: very high adhesion, without any curling at the edge of the mask
4點:附著度高,面膜邊緣輕微翻翹 4 points: high adhesion, slight curling of the edge of the mask
3點:附著度普通,面膜部分剝落 3 points: normal adhesion, partial peeling of the mask
2點:附著度低,面膜明顯剝落 2 points: the adhesion is low, the mask peels off obviously
1點:附著度非常低,面膜完全剝落 1: The adhesion is very low, and the mask is completely peeled off
3.剝除容易度3. Ease of stripping
本發明所稱之剝除容易度係將實施例1至實施例7及比較例1至比較例5的面膜組成物塗覆於受試者之臉部所進行之試驗,其中實施例及比較例各有50位受試者。在歷經八小時後,經水濕潤後,徒手剝除面膜,根據剝除面膜的容易度、面膜剝除之完整度、面膜剝除後有無殘留進行評價,且其具體評價標準如下,其結果如表2所示。 The ease of peeling referred to in the present invention refers to a test conducted by applying the mask compositions of Examples 1 to 7 and Comparative Examples 1 to 5 to the face of a subject. Examples and Comparative Examples There are 50 subjects each. After 8 hours, after moistening with water, peel off the mask with bare hands, and evaluate it according to the ease of peeling off the mask, the completeness of the mask removal, and whether there is any residue after the mask is removed. The specific evaluation criteria are as follows. The results are as follows: Table 2 shows.
5點:剝除時,面膜不破裂,可一次整片撕除 5 points: When peeling off, the mask does not break, and can be peeled off at once
4點:剝除時,面膜稍有破裂,但仍可一次整片撕除 4 points: When peeling off, the mask is slightly broken, but it can still be peeled off at once
3點:剝除時,面膜破裂,需多次撕除 3 points: When peeling off, the mask breaks and needs to be peeled off several times
2點:剝除時,面膜破裂並產生碎屑物之殘留,需多次撕除 2 points: When peeling off, the mask will rupture and produce debris residue, which needs to be peeled off several times
1點:剝除時,面膜破裂成碎屑物而殘留於臉上,且無 法以片狀型態撕除 1 point: When peeling off, the mask breaks into debris and remains on the face, and there is no Method to tear off
4.保濕效果4. Moisturizing effect
本發明所稱之保濕效果係以12位受試者進行試驗,採取雙盲試驗法。在受試者以清水洗淨臉部後,待在控制溫度(24℃至26℃)與濕度(50%至60%)之房間中使皮膚馴化30分鐘,然後使用表皮水分測定儀(Corneometer CM825,Courage-Khazaka electronic GmbH,德國)進行測定受試者臉頰兩側之角質層含水量,其單位為任意電容單位(arbitrary capacitance units,A.C.U)。接著,將實施例2的組成物塗覆於受試者臉部,以形成約0.2毫米之厚度的面膜。在歷經八小時後,經水濕潤後剝除面膜。以前述 之馴化方式馴化皮膚後,再次測定受試者臉頰兩側之角質層含水量。然後,計算出相對於塗覆上述組成物之前的角質層含水量之增加百分比(%),並以含水量之增加百分比來表示保濕效果,再以相同的方式測定實施例5、實施例6、比較例3及比較例4的組成物之保濕效果,其結果如表2所示。 The moisturizing effect referred to in the present invention is tested with 12 subjects, and a double-blind test method is adopted. After the subjects washed their face with clean water, they were allowed to acclimate their skin for 30 minutes in a room with controlled temperature (24°C to 26°C) and humidity (50% to 60%), and then used an epidermal moisture meter (Corneometer CM825) , Courage-Khazaka electronic GmbH, Germany) was used to measure the water content of the stratum corneum on both sides of the subject’s cheeks in arbitrary capacitance units (ACU). Next, the composition of Example 2 was applied to the subject's face to form a mask with a thickness of about 0.2 mm. After eight hours, moisten the mask with water and peel off the mask. In the foregoing After the skin is domesticated, the water content of the horny layer on both sides of the subject’s cheeks is measured again. Then, the percentage increase (%) relative to the water content of the stratum corneum before applying the above composition was calculated, and the percentage increase in water content was used to express the moisturizing effect, and the same method was used to measure Example 5, Example 6, and Example 5. The results of the moisturizing effects of the compositions of Comparative Example 3 and Comparative Example 4 are shown in Table 2.
表2
請參閱表2及圖1A至圖1F,其中表2係前述之舒適感、貼膚度、剝除容易度及保濕效果之評價試驗的結果,且圖1A至圖1B、圖1C至圖1D及圖1E至圖1F分別係本發明之實施例2、比較例3及比較例5之面膜組成物塗覆於受試者臉部後,歷經8小時的照片。 Please refer to Table 2 and Figures 1A to 1F, where Table 2 is the results of the aforementioned evaluation test of comfort, adhesion, ease of peeling and moisturizing effect, and Figures 1A to 1B, 1C to 1D and Figures 1E to 1F are photographs of the facial mask composition of Example 2, Comparative Example 3, and Comparative Example 5 of the present invention after being applied to the face of a subject, after 8 hours.
表2顯示:相較於比較例1的8重量百分比聚氨酯-35(A-1)之組成物,實施例2的12重量百分比聚氨酯-35(A-1)之組成物所形成之面膜具有較佳的剝除容易度。相較於比較例2的22重量百分比聚氨酯-35(A-1)之組成物,實施例2的12重量百分比聚氨酯-35(A-1)之組成物所形成之面膜具有較佳的舒適感。相較於比較例3及比較例4未添加PEG/PPG/聚丁基二醇-8/5/3甘油(B)之組成物,實施例2、實施例5及實施例6之添加PEG/PPG/聚丁基二醇-8/5/3甘油(B)之組成物所形成之面膜具有較佳的舒適 感、貼膚度、剝除容易度及保濕效果,其中整體而言,以實施例2的3重量百分比之使用量的效果為更佳。 Table 2 shows: Compared with the composition of 8 weight percent polyurethane-35 (A-1) of Comparative Example 1, the facial mask formed by the composition of 12 weight percent polyurethane-35 (A-1) of Example 2 has higher Good ease of peeling. Compared with the composition of 22 weight percent polyurethane-35 (A-1) of Comparative Example 2, the mask formed by the composition of 12 weight percent polyurethane-35 (A-1) of Example 2 has better comfort . Compared with the composition of Comparative Example 3 and Comparative Example 4 without adding PEG/PPG/polybutyl glycol-8/5/3 glycerol (B), Example 2, Example 5 and Example 6 add PEG/ The mask formed by the composition of PPG/polybutyl glycol-8/5/3 glycerin (B) has better comfort Feel, stickiness, ease of peeling, and moisturizing effect. Overall, the effect of using the 3 weight percent of Example 2 is better.
5.角質層受損程度5. The degree of damage to the stratum corneum
本發明所稱之角質受損程度係將實施例2及比較例5之面膜組成物塗覆於受試者之臉部,在歷經八小時後,實施例2之面膜組成物所形成之面膜經水濕潤後,徒手剝除面膜,且比較例5之面膜組成物所形成之面膜直接徒手剝除。以顯微鏡觀察塗覆面膜組成物前及剝除面膜後之皮膚表面的角質層,根據角質層的外觀進行評價,且其具體評價標準如下,其結果如表3及圖2A至圖2D所示。 The degree of keratin damage referred to in the present invention means that the facial mask composition of Example 2 and Comparative Example 5 was applied to the subject’s face. After eight hours, the facial mask formed by the facial mask composition of Example 2 passed through After the water was wet, the mask was peeled off with bare hands, and the mask formed by the mask composition of Comparative Example 5 was directly peeled off with bare hands. The stratum corneum on the skin surface before applying the mask composition and after peeling off the mask was observed under a microscope, and evaluated based on the appearance of the stratum corneum, and the specific evaluation criteria are as follows. The results are shown in Table 3 and FIGS. 2A to 2D.
○:角質層外觀光滑,且角質層沒有受損的情況 ○: The appearance of the stratum corneum is smooth, and the stratum corneum is not damaged
×:角質層外觀粗糙,且角質層有受損的情況 ×: The appearance of the stratum corneum is rough and the stratum corneum is damaged
6.隔離效果6. Isolation effect
本發明所稱之隔離效果係以透氣膠帶(由台灣明尼蘇達礦業製造公司製造,且產品名為3M透氣膠帶)模擬具有毛細孔的皮膚,於透氣膠帶的一側上塗覆實施例2之面膜組成物及覆蓋比較例8的面膜,並保留未塗覆面膜組成物的區域做為空白組。在形成面膜後,於面膜及未塗覆面膜組成物的膠帶上塗佈口紅及粉底,並以膠帶的另一側疊放在四層紙巾上,經過90分鐘後,根據口紅及粉底從透氣膠帶至紙巾的滲透,評價實施例2之面膜組成物形成的面膜及比較例8之面膜對於彩妝的隔離效果,且其具體評價標準如下,其結果如表3及圖3A至圖3B所示。 The isolation effect referred to in the present invention is a breathable tape (manufactured by Taiwan Minnesota Mining Manufacturing Company, and the product name is 3M breathable tape) to simulate skin with pores, and the mask composition of Example 2 is coated on one side of the breathable tape And cover the facial mask of Comparative Example 8, and leave the area not coated with the facial mask composition as the blank group. After the mask is formed, apply lipstick and foundation on the mask and the uncoated tape of the mask composition, and stack the other side of the tape on four layers of paper towels. After 90 minutes, remove the breathable tape from the lipstick and foundation. To the penetration of paper towels, the mask formed by the mask composition of Example 2 and the mask of Comparative Example 8 were evaluated for their isolation effect on color makeup, and the specific evaluation criteria are as follows. The results are shown in Table 3 and FIGS. 3A to 3B.
○:塗佈後,口紅及粉底沒有滲透到紙巾 ○: After application, the lipstick and foundation did not penetrate the tissue
×:塗佈後,口紅及粉底有滲透到紙巾 ×: After application, the lipstick and foundation have penetrated into the tissue
7.抗附著性7. Adhesion resistance
本發明所稱之抗附著性係以塗覆實施例2之面膜組成物、覆蓋比較例8之面膜及塗佈水包油乳液在模擬人類皮膚之豬皮上後,分別在豬皮上塗抹二氧化矽奈米粉體及碳黑,再利用抖動移除非附著的奈米粉體及利用吹風機移除非附著的碳黑,並根據奈米粉體及碳黑附著於豬皮上的量,評價實施例2面膜組成物形成之面膜及比較例8之面膜對奈米粉體及碳黑的抗附著性。前述塗覆乳液的豬皮代表僅塗覆乳液的皮膚,且以乳液組標示。此外,使用玻片取代豬皮且以海砂取代奈米粉體,以評價實施例2面膜組成物形成之面膜及比較例8之面膜對海砂的抗附著性,且其具體評價標準如下,其結果如表3及圖4A至圖4C所示。 The anti-adhesion property referred to in the present invention is based on coating the mask composition of Example 2, covering the mask of Comparative Example 8, and coating the oil-in-water emulsion on pig skin that simulates human skin. Silicon oxide nanopowder and carbon black, then shake to remove the non-adhered nanopowder and use a hair dryer to remove the unattached carbon black, and evaluate the examples based on the amount of nanopowder and carbon black attached to the pigskin 2. Adhesion resistance of the mask formed by the mask composition and the mask of Comparative Example 8 to nanopowder and carbon black. The aforementioned lotion-coated pig skin represents skin only coated with lotion, and is labeled as lotion group. In addition, a glass slide was used instead of pig skin and sea sand was used instead of nanopowder to evaluate the adhesion resistance of the mask formed by the mask composition of Example 2 and the mask of Comparative Example 8 to sea sand, and the specific evaluation criteria are as follows: The results are shown in Table 3 and Figures 4A to 4C.
○:奈米粉體、碳黑或海砂不容易附著於豬皮或玻片上,幾乎沒有奈米粉體、碳黑或海砂附著於豬皮或玻片上 ○: Nano powder, carbon black or sea sand is not easy to adhere to pig skin or glass slide, and almost no nano powder, carbon black or sea sand adheres to pig skin or glass slide
×:奈米粉體、碳黑或海砂容易附著於豬皮或玻片上,大量的奈米粉體、碳黑或海砂附著於豬皮或玻片上 ×: Nano powder, carbon black or sea sand is easy to adhere to pig skin or glass slide, and a large amount of nano powder, carbon black or sea sand adheres to pig skin or glass slide
8.彩妝的移除容易度8. Easy to remove makeup
本發明所稱之彩妝的移除容易度係塗覆實施例2之面膜組成物於受試者的手臂皮膚上。在形成面膜後,於形成之面膜及未塗覆的皮膚(代表空白組)上進行彩妝。在經過移除彩妝的處理後,根據彩妝的殘留,評價彩妝的移除容易度,其中實施例2使用少許的常溫水噴灑於面膜上,在面膜經濕潤後,以手剝除面膜並移除彩妝,而空白組使用大量 的水來清洗彩妝。具體評價標準如下,其結果如表3及圖5A至圖5B所示。 The ease of removal of makeup referred to in the present invention is to apply the mask composition of Example 2 on the arm skin of the subject. After forming the mask, apply makeup on the formed mask and uncoated skin (representing the blank group). After the process of removing the makeup, the ease of removal of the makeup was evaluated according to the residue of the makeup. Example 2 used a small amount of room temperature water to spray on the mask. After the mask was moistened, the mask was peeled off by hand and removed Makeup, while the blank group uses a lot Water to clean makeup. The specific evaluation criteria are as follows, and the results are shown in Table 3 and FIGS. 5A to 5B.
○:沒有彩妝殘留 ○: No makeup residue
×:彩妝仍有殘留,且幾乎沒有被移除 ×: Make-up still remains, and it has hardly been removed
表3
請參閱表3及圖2A至圖2D,其中圖2A及圖2C分別為實施例2及比較例5之受試者的角質層在塗覆面膜組成物前之照片,且圖2B及圖2D係分別根據圖2A及圖2C之受試者角質層經剝除實施例2與比較例5面膜組成物形成之面膜後之照片。結果顯示:相較於比較例5之聚乙烯醇/聚乙烯吡咯烷酮之組成物,實施例2之聚氨酯-35(A-1)之組成物所形成之面膜具有較低的角質層受損程度。 Please refer to Table 3 and Figures 2A to 2D, where Figures 2A and 2C are photos of the stratum corneum of the subjects of Example 2 and Comparative Example 5 before applying the mask composition, and Figures 2B and 2D are According to the photographs of Figs. 2A and 2C of the test subject’s stratum corneum after peeling off the masks of Example 2 and Comparative Example 5, respectively. The results show that compared with the polyvinyl alcohol/polyvinylpyrrolidone composition of Comparative Example 5, the facial mask formed by the composition of Polyurethane-35 (A-1) of Example 2 has a lower degree of damage to the stratum corneum.
請參閱表3及圖3A至圖3B,其中圖3A為實施例2及比較例8之透氣膠帶塗佈口紅(紅色區塊)及粉底(淺褐色區塊)之照片,且圖3B為緊鄰圖3A的透氣膠帶之紙巾吸收從透氣膠帶滲透的口紅及粉底的照片。實施例2的紙巾部分沒有口紅及粉底的滲透,但比較例8的紙巾部分顯示有口紅及粉底的滲透,其結果顯示:相較於比較例8 之貼片式面膜,實施例2之聚氨酯-35(A-1)之組成物所形成之面膜具有有效的隔離彩妝之功效。 Please refer to Table 3 and Figures 3A to 3B, in which Figure 3A is a photo of the breathable tape coated lipstick (red area) and foundation (beige brown area) of Example 2 and Comparative Example 8, and Figure 3B is a close-by view The paper towel of the 3A breathable tape absorbs the photos of the lipstick and foundation penetrating through the breathable tape. The tissue part of Example 2 has no penetration of lipstick and foundation, but the tissue part of Comparative Example 8 shows penetration of lipstick and foundation. The results show that: compared to Comparative Example 8. The patch type mask, the mask formed by the composition of the polyurethane-35 (A-1) of Example 2 has the effect of effectively isolating color makeup.
請參閱表3及圖4A至圖4C,其中圖4A係實施例2與比較例8之豬皮經奈米粉體抗附著性試驗後之照片,圖4B係實施例2與比較例8之豬皮經碳黑抗附著性試驗後之照片,且圖4C係實施例2與比較例8之玻片經海砂抗附著性試驗後之照片。在圖4A至圖4C中,實施例2的豬皮附著較少的奈米粉體及碳黑,且實施例2的玻片附著較少的海砂。 Please refer to Table 3 and Figures 4A to 4C, where Figure 4A is a photo of pig skins of Example 2 and Comparative Example 8 after the nanopowder anti-adhesion test, and Figure 4B is a photo of pig skins of Example 2 and Comparative Example 8. The photos after the carbon black adhesion resistance test, and FIG. 4C is the photos of the glass slides of Example 2 and Comparative Example 8 after the sea sand adhesion resistance test. In FIGS. 4A to 4C, the pig skin of Example 2 has less nanopowder and carbon black attached, and the glass slide of Example 2 has less sea sand attached.
前述結果顯示:相較於比較例8之貼片式面膜,實施例2之駐留型面膜組成物形成之面膜對於奈米粉體、碳黑及海砂具有良好的抗附著性之功效。 The foregoing results show that, compared with the patch mask of Comparative Example 8, the mask formed by the resident mask composition of Example 2 has good anti-adhesion effects on nanopowder, carbon black and sea sand.
請參閱表3及圖5A至圖5B,其中圖5A為實施例2之受試者手臂皮膚經彩妝之照片(左側)及未塗覆面膜的手臂皮膚經彩妝之照片(右側)。圖5B為根據圖5A經移除彩妝處理後的照片。圖5A顯示彩妝服貼於實施例2之面膜組成物形成的面膜上且不暈染,並且面膜上的彩妝具有與皮膚上的彩妝相同的妝感。此外,面膜上的彩妝可藉由少許的常溫水濕潤面膜後,在剝除面膜的同時被移除。如前所述,由於實施例2的面膜具有良好的剝除容易度且可有效隔離彩妝,所以在剝除面膜的同時可輕鬆且完全地移除彩妝。在未塗覆面膜的皮膚則使用水清洗,但無法藉由大量的水洗掉彩妝。前述結果顯示:實施例2之面膜組成物所形成之面膜具有良好的彩妝移除容易度。 Please refer to Table 3 and FIGS. 5A to 5B, where FIG. 5A is a photo of the arm skin of the subject of Example 2 with makeup (left side) and a photo of the arm skin without facial mask applied with makeup (right). Fig. 5B is a photo after the makeup removal process according to Fig. 5A. FIG. 5A shows that the makeup clothes are attached to the mask formed by the mask composition of Example 2 without blooming, and the makeup on the mask has the same makeup feel as the makeup on the skin. In addition, the makeup on the mask can be removed when the mask is moistened with a little water at room temperature. As mentioned above, since the facial mask of Example 2 has good peeling ease and can effectively isolate makeup, the makeup can be easily and completely removed while peeling off the mask. The uncoated skin is washed with water, but the makeup cannot be washed off with a lot of water. The foregoing results show that the mask formed by the mask composition of Example 2 has good makeup removal ease.
9.美白效果9. Whitening effect
美白效果試驗係以4位受試者評估實施例8至實施例10、比較例6至比較例7塗覆或不塗覆組成物之美白效果。將受試者的手臂皮膚以12%月桂基聚氧乙烯醚硫酸鈉(sodium lauryl ether sulfate,SLES)泡沫清潔劑洗淨後,在面積為2cm2的手臂皮膚上,敷用30%二羥丙酮溶液40分鐘,再以清水沖淨,並等待24小時讓皮膚的角質充分褐化,以模擬皮膚曬黑的狀態,其皮膚外觀如圖6A所示。然後,以皮膚黑/紅色素探棒(Mexameter MX18,Courage-Khazaka electronic GmbH,德國)及皮膚色澤度探棒(Colorimeter CL400,Courage-Khazaka electronic GmbH,德國)測定受試者皮膚之表皮黑色素含量及L值,且計算個體類型角(individual typology angle,ITA),以做為皮膚「處理前」之數據。 The whitening effect test is to evaluate the whitening effect of the coated or uncoated composition of Example 8 to Example 10, and Comparative Example 6 to Comparative Example 7 with 4 subjects. After washing the subject’s arm skin with a 12% sodium lauryl ether sulfate (SLES) foam cleanser, apply 30% dihydroxyacetone on the arm skin with an area of 2 cm 2 The solution was rinsed with water for 40 minutes, and then waited for 24 hours to fully brown the keratin of the skin to simulate the state of tanning. The appearance of the skin is shown in Figure 6A. Then, the skin black/red pigment probe (Mexameter MX18, Courage-Khazaka electronic GmbH, Germany) and the skin color probe (Colorimeter CL400, Courage-Khazaka electronic GmbH, Germany) were used to measure the epidermal melanin content and L value, and calculate the individual typology angle (ITA), as the skin "before processing" data.
皮膚黑/紅色素探棒係藉由測定特定波長的已知光量之光照射在皮膚後反射光量來獲得被皮膚吸收的光量,並以其表示黑色素含量,其單位為任意比色計單位(arbitrary mexameter unit)。 The skin black/red pigment probe obtains the amount of light absorbed by the skin by measuring the amount of light reflected on the skin with a known amount of light of a specific wavelength, and expresses the melanin content with it. The unit is arbitrary colorimeter unit (arbitrary mexameter unit).
ITA係基於CIE(國際照明委員會)L*a*b*顏色空間建立的皮膚顏色測量指標,其中ITA愈高,表示美白效果愈佳,且ITA可經由下式(I)計算出:ITA(度)={Arc Tangent[(L-50)/b]}×180/π (I) ITA is a skin color measurement index established based on the CIE (International Commission on Illumination) L*a*b* color space. The higher the ITA, the better the whitening effect, and the ITA can be calculated by the following formula (I): ITA (degrees) )={Arc Tangent[(L-50)/b]}×180/π (I)
L值代表明暗度,數值從0(黑)到100(白) The L value represents the brightness, and the value ranges from 0 (black) to 100 (white)
b值代表黃/藍光度 b value represents yellow/blue light
然後,將實施例8至實施例10及比較例6至比較例7之組成物塗覆於受測者之皮膚上,以形成面膜,其中組成物的塗覆量為120mg,經過8小時後剝除面膜。以每日一次的頻率連續進行5日後,測定有塗覆面膜及未塗覆面膜之受試者皮膚的表皮黑色素含量及L值,且計算ITA,以做為皮膚「處理後」之數據,並計算黑色素含量、L值及ITA之變化率,以評估實施例及比較例之美白效果。上述結果如表4所示,而處理後的皮膚外觀如圖6B所示。 Then, the composition of Example 8 to Example 10 and Comparative Example 6 to Comparative Example 7 was coated on the skin of the test subject to form a facial mask, wherein the coating amount of the composition was 120 mg, and it was peeled off after 8 hours. In addition to the mask. After 5 consecutive days at a frequency of once a day, the epidermal melanin content and L value of the subjects with and without the mask were measured, and the ITA was calculated as the "after-treatment" data of the skin, and Calculate the melanin content, the L value and the rate of change of ITA to evaluate the whitening effects of the Examples and Comparative Examples. The above results are shown in Table 4, and the appearance of the treated skin is shown in Fig. 6B.
有關黑色素含量、L值及ITA之變化率,計算方式如式(II)所示: Regarding the change rate of melanin content, L value and ITA, the calculation method is shown in formula (II):
請參閱表4、圖6A及圖6B,其中表4係前述美白效果試驗之結果,並且圖6A係受試者手臂皮膚經過二羥丙酮溶液處理後之照片,以及圖6B係根據圖6A之受試者的手臂皮膚經塗覆或不塗覆實施例8至實施例10及比較例6至比較例7之組成物後的照片。 Please refer to Table 4, Figure 6A and Figure 6B, in which Table 4 is the result of the aforementioned whitening effect test, and Figure 6A is a photo of the subject's arm skin after treatment with dihydroxyacetone solution, and Figure 6B is a photo taken according to Figure 6A. A photograph of the arm skin of the test subject after coating or not coating the compositions of Example 8 to Example 10 and Comparative Example 6 to Comparative Example 7.
表4
從表4、圖6A及圖6B顯示:相較於比較例6及比較例7之未添加PEG/PPG/聚丁基二醇-8/5/3甘油(B)之組成物,實施例8、實施例9及實施例10之添加PEG/PPG/聚丁基二醇-8/5/3甘油(B)之組成物所形成之面膜對於受試者手臂皮膚具有較佳之美白效果,其中以實施例8的3重量百分比之使用量的美白效果為更佳。此顯示PEG/PPG/聚丁基二醇-8/5/3甘油(B)可增強本發明之駐留型面膜之組成物中傳明酸(G1-2)與視黃醇(G2-1)的美白效果。 From Table 4, Figure 6A and Figure 6B, it is shown that Example 8 is compared to the composition of Comparative Example 6 and Comparative Example 7 without adding PEG/PPG/polybutyl glycol-8/5/3 glycerol (B) , Example 9 and Example 10 added PEG/PPG/polybutyl glycol-8/5/3 glycerin (B) composition formed by the mask has a better whitening effect on the arm skin of the test subject, among them The whitening effect of the usage amount of 3% by weight of Example 8 is better. This shows that PEG/PPG/polybutylene glycol-8/5/3 glycerin (B) can enhance tranexamic acid (G1-2) and retinol (G2-1) in the composition of the retention mask of the present invention The whitening effect.
綜上所述,應用本發明之駐留型面膜之組成物,藉由控制成膜劑(A)的使用量以及成膜劑(A)與保濕滲透劑(B)之重量比值,由此形成之駐留型面膜經使用一段預設期間後,確實能提供良好的舒適感、貼膚度、剝除容易度及保濕效果,又可有效隔離彩妝及抗附著污染物。再者,由於良好的剝除容易度,所以剝除面膜不會導致皮膚角質受損,並且在使用少許的常溫水濕潤面膜後,即可剝除面膜並同時移除在面膜上的彩妝。此外,本發明之駐留型面膜之組成物藉由保濕滲透劑(B)可增強活性添加劑(G)之經皮滲透度,而有助於提升活性添加劑(G)的功效。 In summary, the composition of the resident facial mask of the present invention is formed by controlling the amount of film-forming agent (A) and the weight ratio of film-forming agent (A) to moisturizing penetrant (B). After being used for a preset period of time, the resident mask can indeed provide good comfort, adhesion, ease of peeling, and moisturizing effect. It can also effectively isolate makeup and resist adhesion of pollutants. Furthermore, due to the good peeling ease, peeling off the mask will not cause skin keratinous damage, and after using a little room temperature water to moisten the mask, the mask can be peeled off and the makeup on the mask can be removed at the same time. In addition, the composition of the resident facial mask of the present invention can enhance the transdermal penetration of the active additive (G) through the moisturizing penetrant (B), thereby helping to enhance the efficacy of the active additive (G).
雖然本發明已以實施方式揭露如上,然其並非用以限定本發明,在本發明所屬技術領域中任何具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 Although the present invention has been disclosed in the above embodiments, it is not intended to limit the present invention. Anyone with ordinary knowledge in the technical field of the present invention can make various changes and modifications without departing from the spirit and scope of the present invention. Retouching, therefore, the scope of protection of the present invention shall be subject to the scope of the attached patent application.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW108148699A TWI754875B (en) | 2019-12-31 | 2019-12-31 | Composition of resident facial mask |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW108148699A TWI754875B (en) | 2019-12-31 | 2019-12-31 | Composition of resident facial mask |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202126281A true TW202126281A (en) | 2021-07-16 |
TWI754875B TWI754875B (en) | 2022-02-11 |
Family
ID=77908595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW108148699A TWI754875B (en) | 2019-12-31 | 2019-12-31 | Composition of resident facial mask |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI754875B (en) |
-
2019
- 2019-12-31 TW TW108148699A patent/TWI754875B/en active
Also Published As
Publication number | Publication date |
---|---|
TWI754875B (en) | 2022-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60029882T2 (en) | Foaming oil gel compositions | |
DE60032389T2 (en) | PREFORMED FILM FOR TOPICAL APPLICATION | |
JPH09508386A (en) | Aqueous topical composition | |
US8158111B2 (en) | Cosmetic composition and a process for preparing said composition | |
WO2008115695A1 (en) | Cosmetic composition for skin tightening | |
JPH0570321A (en) | Cosmetic | |
CN109908004B (en) | Multiple emulsion sunscreen cosmetic and preparation method thereof | |
CH700328B1 (en) | O / W emulsion for the care of the hand. | |
CN115721595A (en) | Body lotion and preparation method thereof | |
CN103330671A (en) | Penetrative tissue-promoting toner composition containing pansy flower extract, guava extract and hydrolyzed pearl | |
JP7430372B2 (en) | pack agent | |
JPH06157271A (en) | Cosmetic | |
JP2002161027A (en) | Methods and compositions for reducing inflammation and erythema | |
JP7305161B2 (en) | skin cosmetics | |
TWI754875B (en) | Composition of resident facial mask | |
CN112494355A (en) | Moisturizing composition and preparation method thereof | |
CN113133967A (en) | Peony essence skin-moistening facial cream and preparation method thereof | |
CN113116751B (en) | Composition of leave-on facial mask | |
CA2383841C (en) | Chemical peeling agent | |
KR102029652B1 (en) | Cosmetic composition for exfoliation | |
KR20180130178A (en) | Liposome and cosmetic composition comprising the same | |
JP7343885B2 (en) | skin cosmetics | |
CN103169644B (en) | Moisturizing lotion composition containing pansy flower extract and hydrolyzed pearl | |
CN103211740B (en) | Moisturizing emulsion composition containing guava extractive and hydrolyzed pearl | |
JP2000053526A (en) | Cosmetic |